sustained release naltrexone implant (DLP-160) / Delpor - LARVOL DELTA

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160) (clinicaltrials.gov) - P1 | N=10 | Completed | Sponsor: Delpor, Inc. | Recruiting ➔ Completed

Trial completion

"@delPortilloJH @JohannesRiffel @ShiunWoei @ghidalg @tsedatangmailc1 @eeearthman @JASRendon @CagdasOzdol @aksyksvsclb @kursatakbuga @cguamanv @_anmco @flzclkclb @FudimMarat @tietamedeiros @GiorgosMGeorgi1 @cardioceptor @AykunMd @FeliceGragnano @OjedaOjeda18" (@ANazmiCalik)

"@delPortilloJH @CardioTuit @DiegoSalasMqz @Barreticos01" (@HugoAlvaradoMo3)

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160) (clinicaltrials.gov) - P1 | N=10 | Recruiting | Sponsor: Delpor, Inc. | Not yet recruiting ➔ Recruiting

Enrollment open

"@berglundMD @giulialavecchi3 @cardioian @jsenior64 @delPortilloJH @ACCintouch @steffneK @spatzerica @marcDweck @NRS_CVResearch @SonaliKumar @RobertoAguero @LydiaRoca @SeanM_Wu @AAPBiofeedback @Coroventis @DrTomWaggoner @Georgehret @adribaran @IndahSP_MD @datsunian" (@InocaInternati1)